Effects of bromocriptine on serum prolactin levels, pituitary weight and immunoreactive prolactin cells in estradiol-treated ovariectomized rats: An experimental model of estrogen-dependent hyperprolactinemia

Brazilian Journal of Medical and Biological Research

Volumn 30, Issue 1, 1997, Pages 113-117

  Ribeiro, M F ^a   Spritzer, P M ^a,c   Barbosa Coutinho, L M ^b   Oliveira, M C ^b   Pavanato, M A ^a   Silva, I S B ^a   Reis, F M ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Bromocriptine; Estrogen; Immunoreactive prolactin cells; Pituitary growth; Prolactin levels

Indexed keywords

ANIMALIA; HELIANTHUS; RATTUS NORVEGICUS;

BROMOCRIPTINE; ESTRADIOL; ESTRADIOL VALERATE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; HYPERPROLACTINEMIA; HYPOPHYSIS; NONHUMAN; ORGAN WEIGHT; OVARIECTOMY; PROLACTIN BLOOD LEVEL; PROLACTIN SECRETING CELL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BROMOCRIPTINE; ESTRADIOL; FEMALE; HYPERPROLACTINEMIA; ORGAN SIZE; OVARIECTOMY; PITUITARY GLAND; PROLACTIN; RATS; RATS, WISTAR;

EID: 0031045402     PISSN: 0100879X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0100-879X1997000100017     Document Type: Article

References (17)

1. Voogt JL, Chen CL & Meites J (1970). Serum and pituitary prolactin levels before, during and after puberty in female rats. American Journal of Physiology, 218: 396-399.
2. Chen CL & Meites J (1970). Effects of estrogen and progesterone on serum and pituitary prolactin levels in ovariectomized rats. Endocrinology, 86: 503-505.
3. Lloyd HM, Meares JD & Jacobi J (1975). Effects of oestrogen and bromocriptine on in vivo secretion and mitosis in prolactin cells. Nature, 255: 497-498.
4. Schussler N, Farnoud R, Rauch C, Roche M, Berthet M, Thomas F, Peillon F & Bayet MC (1994). Effect of the slow-release formulation of somatuline (BIM 23014) on estrogen-induced hyperprolactinemia and lactotroph hyperplasia in the female rat. Neuropeptides, 26: 399-404.
5. Foord SM, Peters JR, Dieguez C, Scanlon MF & Hall R (1983). Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin. Endocrinology, 112: 1567-1577.
6. Trouillas J, Chevallier P, Claustrat B, Hooghe-Peters E, Dubray C, Rousset B & Girod C (1994). Inhibitory effects of the dopamine agonists quinagolide (CV 205-502) and bromocriptine on prolactin secretion and growth of SMtTW pituitary tumours in the rat. Endocrinology, 134: 401-410.
7. Friedman E, Adams EF, Hoog A, Gejman PV, Carson E, Larsson C, De Marco L, Werner S, Fahlbush R & Nordenskjold M (1994). Normal structural dopamine type 2 receptor gene in prolactin-secreting and other pituitary tumors. Journal of Clinical Endocrinology and Metabolism, 78: 568-574.
8. Ferland L, Labrie F, Euvrard C & Raynaud J-P (1979). Antidopaminergic activity of estrogens on prolactin release at the pituitary level in vivo. Molecular and Cellular Endocrinology, 14: 199-204.
9. Chiodini PG, Liuzzi A, Cozzi R, Verde G, Oppizzi G, Dallabonzana D, Spelta B, Silvestrini F, Borghi G, Luccarelli G, Rainer E & Horowski R (1981). Size reduction of macroprolactinomas by bromocriptine or lisuride treatment. Journal of Clinical Endocrinology and Metabolism, 53: 737-743.
10. Tindall GT, Kovacs K, Horvath E & Thorner MO (1982). Human prolactin-producing adenomas and bromocriptine: A histologic, immunocytochemical, ultrastructural, and morphometric study. Journal of Clinical Endocrinology and Metabolism, 55: 1178-1183.
11. Lyle SF, Wright K & Collins DC (1984). Comparative effects of tamoxifen and bromocriptine on prolactin and pituitary weight in estradiol-treated male rats. Cancer, 53: 1473-1477.
12. Casanueva F, Cocchi D, Locatelli V, Flauto C, Zambotti F, Bestetti G, Rossi GL & Müller E (1982). Defective central nervous system dopaminergic function in rats with estrogen-induced pituitary tumours, as assessed by plasma prolactin concentrations. Endocrinology, 110: 590-599.
13. Oliveira MC, Spritzer PM, Poy M, Coronel AX, Dahlem N, Moraes JT & Barbosa-Coutinho LM (1993). Progestin effects on prolactin secretion and on immunoreactive prolactin cells in estradiol-treated ovariectomized rats. Hormone and Metabolic Research, 25: 600-602.
14. Phelps CJ & Himer WC (1988). Effects of bromocriptine on prolactin cellular hypertrophy, proliferation and secretory activity in diethylstilbestrol-induced pituitary tumors. Molecular and Cellular Endocrinology, 58: 137-148.
15. McComb DJ, Hellmann P, Thorner MO, Scott D, Evans WS & Kovacs K (1986). Morphologic effects of bromocriptine on spontaneously occurring pituitary prolactin-cell hyperplasia in old Long-Evans rats. American Journal of Pathology, 122: 7-16.
16. Spritzer PM, Ribeiro MF, Oliveira MC, Barbosa-Coutinho LM, Silva ISB, Dahlem N, Cericatto R & Pavanato MA (1996). Effects of tamoxifen on prolactin levels, pituitary immunoreactive prolactin cells and uterine growth in estradiol-treated ovariectomized rats. Hormone and Metabolic Research, 28: 171-176.
17. Paradisi R, Grossi G, Pintore A, Venturoli S, Porcu E, Capelli M & Flamigni C (1991). Evidence for a pathological reduction in brain dopamine metabolism in idiopathic hyperprolactinemia. Acta Endocrinologica, 125: 246-252.